about
Optimized Particle Swarm Optimization (OPSO) and its application to artificial neural network trainingBinding to large enzyme pockets: small-molecule inhibitors of trypanothione reductaseStructural insights on cholesterol endosynthesis: Binding of squalene and 2,3-oxidosqualene to supernatant protein factorDe Novo Fragment Design for Drug Discovery and Chemical BiologyAn unusual ERAD-like complex is targeted to the apicoplast of Plasmodium falciparumAdvances in the prediction of protein targeting signalsVirtual screening: an endless staircase?Inhibitors of Helicobacter pylori protease HtrA found by 'virtual ligand' screening combat bacterial invasion of epitheliaBioassays to monitor Taspase1 function for the identification of pharmacogenetic inhibitorsSpherical harmonics coefficients for ligand-based virtual screening of cyclooxygenase inhibitorsDOGS: reaction-driven de novo design of bioactive compounds11th German Conference on Chemoinformatics (GCC 2015) : Fulda, Germany. 8-10 November 2015.Properties and prediction of mitochondrial transit peptides from Plasmodium falciparumPrivileged Structures Revisited.Virtual screening and fast automated docking methods.PocketPicker: analysis of ligand binding-sites with shape descriptors.Prediction of turn types in protein structure by machine-learning classifiers.Fractal Dimensions of Macromolecular Structures.Erratum: Fractal Dimensions of Macromolecular Structures.Computer-assisted quantification of motile and invasive capabilities of cancer cells.Ligand-based combinatorial design of selective purinergic receptor (A2A) antagonists using self-organizing maps.Development of a virtual screening method for identification of "frequent hitters" in compound libraries.A virtual screening method for prediction of the HERG potassium channel liability of compound libraries.SVM-based feature selection for characterization of focused compound collections.Trends in virtual combinatorial library design.Hybrid Network Model for "Deep Learning" of Chemical Data: Application to Antimicrobial Peptides.Support vector machine applications in bioinformatics.Fuzzy pharmacophore models from molecular alignments for correlation-vector-based virtual screening.Impact of different software implementations on the performance of the Maxmin method for diverse subset selection.A hierarchical clustering approach for large compound libraries.A pseudo-ligand approach to virtual screening.NIPALSTREE: a new hierarchical clustering approach for large compound libraries and its application to virtual screening.Molecular query language (MQL)--a context-free grammar for substructure matching.Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening.Processing and classification of chemical data inspired by insect olfactionThe Plasmodium export element revisitedConcept of combinatorial de novo design of drug-like molecules by particle swarm optimization.Identification of hits and lead structure candidates with limited resources by adaptive optimization.Domain organization of long signal peptides of single-pass integral membrane proteins reveals multiple functional capacity.PhAST: pharmacophore alignment search tool.
P50
Q21284277-11F2CBCA-81FD-4983-A519-C840EB556160Q27690137-28F33F36-7AB7-4344-84A3-25F0FE6A6C58Q27700869-F8628187-2864-4105-821B-E09F2DD0C83BQ27702495-01E545FF-7B9C-41E5-8F8B-2EB2FC15040CQ27973185-896302DB-D3FE-4290-8EBF-3A38D08DA1A2Q28264601-51DDB76D-183B-4B27-B1C4-06B3BC338A13Q28278411-9E4DBB2C-2C10-4B82-ABD0-B0F14DB01B39Q28477589-3A15DF31-2EC8-4A15-911F-52AD2AB1E668Q28478269-B1CC9972-C067-4C00-8957-F19682DBEB03Q28479435-C4BBDD13-1269-4F63-A264-BAD4BF6463FDQ28480868-45CFD251-9510-484E-97BE-CDC1F14B61E6Q28550032-25FB20F0-43AA-4686-83E7-F078A3EADB6EQ30041698-D9626951-08D5-49D1-8F91-5D847443946EQ30101030-0D21974A-0AFF-48A2-9110-3ED7AAA88FB1Q30329412-29EC8ED2-A5BC-441B-A659-C8BD1271AA63Q30364721-04F60C6F-E402-406C-BD50-AFB8C78241D3Q30370580-4D8A45EB-CFA7-4D4E-B580-522BC0FCE136Q30377207-CF5E278A-B346-4270-A579-442CD159972CQ30391371-9478318D-5F3C-46CD-A5EA-EB2CE1DB4A44Q30669870-2B6D8A6A-1CDE-4386-AFBB-41D93871621EQ30726331-14962D71-E0CC-43FC-871B-B5F50294EF5CQ30783737-DF166045-7A59-4C9D-9F19-240DA1BC211DQ31054826-A58F94DD-D1BF-4B4D-B384-433004E2CD0DQ31063951-105B814A-8BBA-4972-80D8-69CE7E721A76Q31120448-061B1602-1946-4493-B5B3-51937563EB89Q31156988-53FA94F0-C4F7-499E-99F6-2B62F99B250EQ33202710-90FE50C9-4068-4A35-8D39-00D0F6222135Q33206330-5E9AAD36-8931-4133-BEDD-3C1117752C1FQ33210254-F1EDA7A4-4105-49D1-AB1F-DB4B98DBF14CQ33220363-96259911-9E75-4755-BF1F-1CA5E19D4BE7Q33247323-FF885CB8-D986-4D81-9E32-5A85C39F4B59Q33264558-2D94AC46-0FF5-4B22-AD52-763B1AF69162Q33279799-E7CE1E22-AB5F-406B-A483-849EC5D514ADQ33282886-EFDD84F6-8F52-4296-B392-0F4021968374Q33310140-E4D2B98A-985A-48CF-B2EF-AEAA307E1640Q33318468-81D97C1F-5ED9-4313-856E-E0F133CD00DAQ33344947-CC36FB4F-1E44-4B95-8750-2FF2620FEB7CQ33347794-0C30614F-5CC8-43E0-8437-4ACC5C914995Q33354073-E8E5BC31-CF92-45BA-8652-552AFB186F1BQ33363411-6C9F03F5-3AFB-41CF-9D98-F0CFA5118287
P50
subject
description
chemist working in Switzerland
@en
scheikundige
@nl
name
Gisbert Schneider
@ast
Gisbert Schneider
@en
Gisbert Schneider
@es
Gisbert Schneider
@nl
Gisbert Schneider
@sl
type
label
Gisbert Schneider
@ast
Gisbert Schneider
@en
Gisbert Schneider
@es
Gisbert Schneider
@nl
Gisbert Schneider
@sl
prefLabel
Gisbert Schneider
@ast
Gisbert Schneider
@en
Gisbert Schneider
@es
Gisbert Schneider
@nl
Gisbert Schneider
@sl
P1006
P214
P1006
P106
P108
P214
P2456
P31
P496
0000-0001-6706-1084
P5361
SchneiderGisbert1965-
P569
1965-10-10T00:00:00Z
P734
P7859
lccn-n94068323